-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our 12-month price target by $5 to $175, using a forward P/E of 20.4x our 2027 EPS estimate of $8.57, broadly in line with historical averages. We raise our 2026 EPS estimate by $0.33 to $7.26 and 2027's by $0.48 to $8.57. We project revenues of $12.9B in 2026 and $13.7B in 2027. While JBHT delivered a solid quarter, with 5% revenue growth and strong 27% EPS growth, we remain doubtful about the company's ability to sustain margin expansion despite aggressive cost-cutting measures. We anticipate several headwinds in 2026, including rising wages due to an ongoing driver shortage, declining driver supply due to new regulatory requirements, and higher insurance costs. We believe the stock is currently overvalued at a forward P/E of 29.9x, which is near its decade high and 33% above its 10-year historical average. This premium is unjustified given the challenges ahead. Despite JBHT increasing its dividend for 22 straight years, shares yield just 0.8%.